marketcaparena
Search

    NTRB

    NutriBand Inc.

    Company overview

    Market capitalization
    $97.25M
    Employees
    0
    Latest publication
    2026-09-29
    About NutriBand Inc.

    Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-07-31 · USDQ4 20262026-01-31 · USDQ3 20262025-10-31 · USDQ2 20262025-07-31 · USDQ1 20262025-04-30 · USDQ4 20252025-01-31 · USDQ3 20252024-10-31 · USDQ2 20252024-07-31 · USD
    Total Revenue437,514USD400,709USD346,058USD622,452USD667,432USD642,379USD645,796USD442,830USD
    Cost Of Revenue255,640USD332,481USD283,031USD473,936USD439,080USD367,757USD466,148USD352,012USD
    Gross Profit181,874USD68,228USD63,027USD148,516USD228,352USD274,622USD179,648USD90,818USD
    Research Development322,194USD188,036USD457,113USD562,554USD683,426USD489,856USD880,768USD773,975USD
    Selling General Administrative750,317USD921,820USD3,491,728USD1,597,540USD982,052USD1,759,655USD737,102USD737,325USD
    Total Operating Expenses1,072,511USD1,089,143USD3,943,363USD2,151,729USD1,641,849USD2,238,000USD1,606,000USD1,501,000USD
    Operating Income-890,637USD-1,020,915USD-3,880,336USD-2,003,213USD-1,413,497USD-1,964,000USD-1,427,000USD-1,410,000USD
    Total Other Income Expense Net10,076USD52,856USD7,969USD2,876USD24,628USD-3,553,000USD64,204USD-296,000USD
    Interest Income14,950USD—13,517USD8,649USD30,508USD46,084USD68,235USD77,332USD
    Interest Expense4,874USD5,334USD5,548USD5,773USD5,880USD3,739USD4,031USD5,019USD
    Income Before Tax-880,561USD-968,059USD-3,872,367USD-2,000,337USD-1,388,869USD-5,516,000USD-1,363,000USD-1,705,000USD
    Income Tax Expense0USD——————1USD
    Net Income-880,561USD-968,059USD-3,872,367USD-2,000,337USD-1,388,869USD-5,516,000USD-1,363,000USD-1,705,000USD
    Net Income Applicable To Common Shares-880,561USD———————
    Net Interest Income—-58,008USD7,969USD2,876USD24,628USD42,345USD64,204USD72,313USD
    Tax Provision—0USD0USD0USD0USD0USD0USD0USD
    Net Income From Continuing Ops—-968,059USD-3,872,367USD-2,000,337USD-1,388,869USD-5,516,438USD-1,362,637USD-1,705,465USD
    Ebit—-1,020,915USD-3,880,336USD-2,003,213USD-1,413,497USD-5,512,853USD-1,358,150USD-1,699,949USD
    Ebitda—-985,036USD-3,837,380USD-1,945,831USD-1,356,017USD-5,440,000USD-1,285,000USD-1,630,000USD
    Depreciation And Amortization—35,879USD42,956USD57,382USD57,480USD72,853USD73,150USD69,949USD
    Reconciled Depreciation—35,879USD43,056USD57,382USD57,480USD72,855USD73,149USD69,949USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-01-31 · USDFY 20252025-01-31 · USDFY 20242024-01-31 · USDFY 20232023-01-31 · USDFY 20222022-01-31 · USDFY 20212021-01-31 · USDFY 20202020-01-31 · USDFY 20192019-01-31 · USD
    Total Revenue2,036,651USD2,140,000USD2,085,314USD2,079,609USD1,422,154USD943,702USD370,647USD245,285USD
    Cost Of Revenue1,513,540USD1,440,000USD1,223,209USD1,329,200USD917,844USD582,378USD549,107USD288,301USD
    Gross Profit523,111USD699,302USD862,105USD750,409USD504,310USD361,324USD-178,460USD-43,016USD
    Research Development1,891,129USD3,119,000USD1,960,425USD982,227USD411,383USD0USD—0USD
    Selling General Administrative6,993,140USD4,313,810USD3,773,606USD3,916,041USD4,022,824USD2,912,269USD1,790,980USD3,288,224USD
    Total Operating Expenses8,841,072USD7,389,000USD5,734,031USD4,898,268USD4,434,207USD2,957,269USD1,790,980USD3,288,224USD
    Operating Income-8,317,961USD-6,690,000USD-4,871,926USD-4,147,859USD-3,929,897USD-2,595,945USD-1,969,440USD-3,331,240USD
    Interest Expense22,535USD21,407USD75,815USD8,289USD118,421USD280,686USD73,413USD0USD
    Net Interest Income-22,535USD170,262USD-58,965USD-8,289USD-118,421USD-349,817USD-73,413USD—
    Income Before Tax-8,229,632USD-10,483,000USD-5,485,314USD-4,483,474USD-6,176,126USD-2,932,828USD-2,721,627USD-3,331,240USD
    Tax Provision0USD0USD0USD0USD0USD0USD0USD0USD
    Net Income-8,229,632USD-10,483,000USD-5,485,314USD-4,810,800USD-8,422,355USD-3,213,514USD-2,795,040USD-3,331,240USD
    Net Income From Continuing Ops-8,229,632USD-10,482,617USD-5,485,314USD-4,483,474USD-6,176,126USD-2,932,828USD-2,721,627USD-3,331,240USD
    Ebit-8,317,961USD-10,461,053USD-5,409,499USD-4,475,185USD-6,057,705USD-2,652,142USD-2,648,214USD-3,331,240USD
    Ebitda-8,124,164USD-10,176,000USD-5,121,777USD-4,106,229USD-5,739,442USD-2,482,424USD-2,556,374USD-3,294,229USD
    Depreciation And Amortization193,797USD285,053USD287,722USD368,956USD318,263USD169,718USD91,840USD37,011USD
    Reconciled Depreciation193,797USD285,054USD287,722USD368,956USD318,263USD169,718USD91,405USD37,011USD
    Total Other Income Expense Net88,329USD-3,793,000USD-613,388USD-335,615USD-2,246,229USD-336,883USD-752,187USD0USD
    Interest Income—191,669USD16,850USD0USD————
    Income Tax Expense——-2USD327,326USD2,246,229USD280,686USD73,413USD-124,130USD
    Net Income Applicable To Common Shares———-4,483,474USD-6,372,715USD-2,932,828USD-2,721,627USD-3,331,240USD
    Selling And Marketing Expenses—————45,000USD——
    Non Operating Income Net Other—————-336,883USD——
    Minority Interest———————0USD
    Discontinued Operations———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-07-31 · USDQ4 20262026-01-31 · USDQ3 20262025-10-31 · USDQ2 20262025-07-31 · USDQ1 20262025-04-30 · USDQ4 20252025-01-31 · USDQ3 20252024-10-31 · USDQ2 20252024-07-31 · USD
    Total Assets6,293,097USD7,547,935USD8,419,160USD10,176,588USD6,152,000USD7,470,000USD12,543,000USD13,634,000USD
    Cash And Equivalents3,421,615USD———————
    Total Current Assets3,819,383USD4,988,718USD5,815,064USD7,520,436USD3,430,000USD4,794,000USD6,192,000USD7,248,000USD
    Total Liabilities964,358USD———————
    Total Current Liabilities907,048USD784,281USD772,524USD1,571,808USD925,051USD982,845USD1,248,000USD1,104,000USD
    Total Stockholder Equity5,328,739USD6,679,488USD7,548,952USD8,493,808USD5,103,000USD6,429,000USD11,232,000USD12,461,000USD
    Total Equity Including Noncontrolling Interest5,328,739USD———————
    Deferred Revenue100,121USD———————
    Net Receivables23,592USD118,404USD147,562USD160,804USD94,136USD73,847USD109,630USD68,011USD
    Inventory170,733USD117,987USD135,998USD138,031USD215,324USD212,041USD168,299USD223,860USD
    Property Plant Equipment Net584,085USD639,255USD668,968USD705,857USD757,073USD695,063USD747,469USD753,218USD
    Goodwill1,719,535USD———————
    Accounts Payable644,518USD—605,209USD1,393,013USD721,671USD698,821USD892,154USD778,827USD
    Short Term Debt33,967USD161,324USD160,341USD159,376USD158,700USD128,144USD136,764USD145,187USD
    Common Stock12,156USD12,156USD12,156USD12,016USD11,130USD11,075USD11,106USD11,096USD
    Retained Earnings-48,814,785USD-46,692,268USD-45,724,209USD-41,851,842USD-39,852,000USD-38,463,000USD-32,946,000USD-31,584,000USD
    Accumulated Other Comprehensive Income-304USD-304USD-304USD-304USD-304USD-304USD-304USD-304USD
    Intangible Assets—200,427USD215,593USD230,760USD245,926USD261,092USD582,418USD610,705USD
    Other Current Assets—177,470USD219,327USD226,500USD156,540USD196,658USD215,486USD196,235USD
    Total Liab—868,447USD870,208USD1,682,780USD1,049,000USD1,041,000USD1,312,000USD1,173,000USD
    Other Current Liab—502,654USD—1,393,013USD—698,821USD892,154USD-17,528USD
    Capital Stock—15,165USD15,165USD15,025USD11,130USD11,075USD11,106USD11,096USD
    Good Will—1,719,535USD1,719,535USD1,719,535USD1,720,000USD1,720,000USD5,022,000USD5,022,000USD
    Cash—4,574,857USD5,312,177USD6,995,101USD2,964,000USD4,312,000USD5,698,000USD6,760,000USD
    Cash And Short Term Investments—4,574,857USD5,312,177USD6,995,101USD2,964,000USD4,312,000USD5,698,000USD6,760,000USD
    Current Deferred Revenue—120,303USD6,974USD19,419USD44,680USD155,880USD218,868USD179,576USD
    Net Debt—-4,365,228USD-5,095,755USD-6,724,753USD-2,682,000USD-4,125,000USD-5,498,000USD-6,546,000USD
    Short Long Term Debt—128,871USD128,619USD128,369USD128,391USD128,144USD127,900USD127,659USD
    Short Long Term Debt Total—209,629USD216,422USD270,348USD282,444USD186,349USD200,481USD214,320USD
    Long Term Debt—35,861USD41,603USD47,290USD52,632USD58,205USD63,717USD69,133USD
    Property Plant Equipment Gross—1,625,984USD1,634,984USD1,643,984USD1,652,984USD1,548,660USD1,556,499USD1,517,386USD
    Common Stock Shares Outstanding—12,155,983shares12,057,153shares11,218,581shares11,125,800shares10,607,000shares11,102,000shares11,062,000shares
    Non Current Assets Total—2,559,217USD2,604,096USD2,656,152USD2,723,000USD2,676,000USD6,352,000USD6,386,000USD
    Non Current Liabilities Total—84,166USD97,684USD110,972USD123,743USD58,205USD63,717USD69,132USD
    Net Working Capital—4,204,437USD5,042,540USD5,948,628USD2,504,596USD3,811,420USD4,943,816USD6,144,483USD
    Unclassified Equity—53,344,739USD53,246,144USD50,318,913USD44,933,044USD44,870,154USD44,156,092USD44,023,112USD
    Unclassified Current Liabilities———-1,521,382USD——-1,019,840USD—
    Non Currrent Assets Other————927USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-01-31 · USDFY 20252025-01-31 · USDFY 20242024-01-31 · USDFY 20232023-01-31 · USDFY 20222022-01-31 · USDFY 20212021-01-31 · USDFY 20202020-01-31 · USDFY 20192019-01-31 · USD
    Total Assets7,547,935USD7,470,000USD7,517,154USD9,456,377USD12,739,660USD9,927,419USD2,197,755USD2,807,618USD
    Intangible Assets200,427USD261,092USD667,280USD780,430USD926,913USD1,006,730USD314,700USD351,770USD
    Other Current Assets177,470USD196,112USD211,667USD365,925USD370,472USD0USD20,167USD205,450USD
    Total Liab868,447USD1,041,000USD1,078,919USD883,387USD880,375USD2,815,473USD2,022,322USD403,006USD
    Total Stockholder Equity6,679,488USD6,429,000USD6,438,235USD8,572,990USD11,859,285USD7,111,946USD175,433USD2,404,612USD
    Other Current Liab502,654USD698,821USD1USD534,679USD639,539USD940,612USD928,774USD71,225USD
    Common Stock12,156USD11,075USD8,860USD7,833USD9,155USD6,257USD5,441USD21,695USD
    Capital Stock15,165USD11,075USD8,860USD7,833USD7,843USD6,257USD5,441USD21,695USD
    Retained Earnings-46,692,268USD-38,463,000USD-27,980,019USD-22,494,705USD-18,011,231USD-11,835,105USD-8,902,277USD-6,180,650USD
    Good Will1,719,535USD1,720,000USD5,021,713USD5,021,713USD5,349,039USD7,529,875USD1,719,235USD1,719,235USD
    Cash4,574,857USD4,312,000USD492,942USD1,985,440USD4,891,868USD151,993USD10,181USD474,653USD
    Cash And Short Term Investments4,574,857USD4,312,000USD492,942USD1,985,440USD4,891,868USD151,993USD10,181USD474,653USD
    Total Current Assets4,988,718USD4,794,000USD1,021,863USD2,693,745USD5,465,368USD314,188USD43,181USD590,466USD
    Total Current Liabilities784,281USD982,845USD999,093USD748,613USD779,256USD2,568,606USD2,022,322USD403,006USD
    Current Deferred Revenue120,303USD155,880USD157,502USD162,903USD106,267USD86,846USD—71,225USD
    Net Debt-4,365,228USD-4,125,000USD-251,657USD-1,799,635USD-4,757,299USD1,636,022USD311,436USD-434,653USD
    Short Term Debt161,324USD128,144USD161,458USD51,031USD33,450USD1,541,148USD321,617USD40,000USD
    Short Long Term Debt128,871USD128,144USD127,183USD19,740USD14,119USD1,516,408USD311,567USD40,000USD
    Short Long Term Debt Total209,629USD186,349USD241,285USD185,805USD134,569USD1,788,015USD321,617USD40,000USD
    Long Term Debt35,861USD58,205USD79,826USD100,497USD101,119USD150,063USD—0USD
    Net Receivables118,404USD73,847USD148,649USD113,045USD71,380USD109,347USD12,833USD13,088USD
    Inventory117,987USD212,041USD168,605USD229,335USD131,648USD52,848USD0USD0USD
    Property Plant Equipment Net639,255USD695,063USD806,298USD960,489USD998,340USD1,076,626USD120,639USD146,147USD
    Property Plant Equipment Gross1,625,984USD1,548,660USD1,487,991USD1,467,610USD1,321,801USD1,076,626USD111,029USD—
    Accumulated Other Comprehensive Income-304USD-304USD-304USD-304USD-304USD-304USD-304USD-52USD
    Common Stock Shares Outstanding11,640,995shares10,607,000shares7,954,105shares8,459,547shares7,932,893shares6,732,766shares6,327,947shares6,244,374shares
    Non Current Assets Total2,559,217USD2,676,000USD6,495,291USD6,762,632USD7,274,292USD9,613,231USD2,154,574USD2,217,152USD
    Non Current Liabilities Total84,166USD58,205USD79,826USD134,774USD101,119USD246,867USD1,093,548USD0USD
    Net Working Capital4,204,437USD3,811,420USD22,770USD1,945,132USD4,686,112USD-2,254,418USD-1,979,141USD187,460USD
    Unclassified Equity53,344,739USD44,870,154USD34,400,838USD31,052,333USD29,853,822USD18,934,841USD9,067,132USD8,541,924USD
    Accounts Payable—698,821USD680,132USD534,679USD639,539USD940,612USD771,931USD291,781USD
    Non Currrent Assets Other—-63USD—-6,762,632USD-7,274,292USD—-2,154,574USD146,147USD
    Net Tangible Assets———2,770,847USD5,583,333USD-1,424,659USD-1,858,502USD333,607USD
    Non Current Liabilities Other—————96,804USD——
    Unclassified Current Liabilities—————-2,457,020USD——
    Other Assets——————9,610USD0USD
    Unclassified Non Current Liabilities——————1,093,548USD—
    Deferred Long Term Liab———————0USD
    Other Liab———————0USD
    Long Term Investments———————0USD
    Short Term Investments———————0USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-07-31 · USD
    Depreciation67,503USD
    Change To Account Receivables94,812USD
    Change To Inventory-52,746USD
    Change To Liabilities141,863USD
    Change In Working Capital183,929USD
    Operating Cash Flow-1,148,103USD
    Financing Cash Flow-5,139USD
    Change In Cash-1,153,242USD
    End Cash Flow3,421,615USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-01-31 · USDQ3 20262025-10-31 · USDQ2 20262025-07-31 · USDQ1 20262025-04-30 · USDQ4 20252025-01-31 · USDQ3 20252024-10-31 · USDQ2 20252024-07-31 · USDQ1 20252024-04-30 · USD
    Net Income-968,059USD-3,872,367USD-2,000,337USD-1,388,869USD-5,516,438USD-1,363,000USD-1,705,465USD-1,898,077USD
    Depreciation35,879USD43,056USD57,382USD57,480USD72,855USD73,149USD69,949USD69,101USD
    Stock Based Compensation98,513USD2,535,483USD41,050USD63,350USD-419,985USD133,350USD130,380USD422,955USD
    Other Non Cash Items9,000USD9,000USD9,000USD9,000USD4,624,324USD429,599USD375,881USD192,938USD
    Change To Account Receivables29,158USD13,242USD-66,668USD-20,289USD35,783USD-41,619USD17,133USD63,505USD
    Change To Inventory18,011USD2,033USD77,293USD-3,283USD-43,742USD55,561USD-53,840USD-1,415USD
    Change In Working Capital92,837USD-467,659USD579,564USD-77,933USD-254,316USD-150,000USD-414,492USD564,250USD
    Total Cash From Operating Activities-731,830USD-1,752,487USD-1,313,341USD-1,336,972USD-1,239,244USD-1,010,000USD-1,543,747USD-833,926USD
    Capital Expenditures-5,324USD0USD-5,324USD-5,324USD-4USD-46,958USD-38,890USD-6,195USD
    Free Cash Flow-731,830USD-1,752,487USD-1,308,017USD-1,336,972USD-1,239,244USD-1,057,000USD-1,582,637USD-840,121USD
    Total Cashflows From Investing Activities-5,324USD-5,324USD5,324USD-5,324USD—-46,958USD-38,890USD-6,195USD
    Net Borrowings-5,490USD-5,437USD-5,364USD-5,326USD-5,268USD-5,175USD-5,136USD—
    Total Cash From Financing Activities-5,490USD69,563USD5,344,345USD-5,326USD-147,224USD-5,175USD-5,136USD8,694,919USD
    Issuance Of Capital Stock0USD0USD5,305,503USD0USD6,591USD0USD0USD8,400,000USD
    Change In Cash-737,320USD-1,682,924USD4,031,004USD-1,347,622USD-1,386,468USD-1,062,000USD-1,587,773USD7,854,798USD
    Begin Period Cash Flow5,312,177USD6,995,101USD2,964,097USD4,311,719USD5,698,187USD6,760,000USD8,347,740USD492,942USD
    End Period Cash Flow4,574,857USD5,312,177USD6,995,101USD2,964,097USD4,311,719USD5,698,000USD6,759,967USD8,347,740USD
    Other Cashflows From Financing Activities-5,490USD—5,349,709USD-5,326USD8,258,044USD-46,958USD-38,890USD-6,195USD
    Other Cashflows From Investing Activities—-5,324USD—-5,324USD6,195USD-92,043USD—-6,195USD
    Investments——0USD-5,324USD0USD-46,958USD-38,890USD-6,195USD
    Unclassified Financing Cash Flow——-5,305,503USD—-8,406,591USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-01-31 · USDFY 20252025-01-31 · USDFY 20242024-01-31 · USDFY 20232023-01-31 · USDFY 20222022-01-31 · USDFY 20212021-01-31 · USDFY 20202020-01-31 · USDFY 20192019-01-31 · USD
    Net Income-8,229,632USD-10,483,000USD-5,485,314USD-4,483,474USD-6,176,126USD-2,932,828USD-2,721,627USD-3,331,240USD
    Depreciation193,797USD285,054USD287,722USD368,956USD318,263USD169,718USD91,405USD37,011USD
    Stock Based Compensation104,400USD1,542,000USD742,696USD732,130USD1,364,732USD2,004,875USD252,700USD1,763,950USD
    Other Non Cash Items2,669,996USD3,994,858USD704,168USD614,506USD2,225,285USD363,888USD91,317USD24,300USD
    Change To Account Receivables-44,557USD74,802USD-153,969USD-41,665USD42,967USD-94,753USD255USD-12,825USD
    Change To Inventory94,054USD-43,436USD60,730USD-97,687USD-78,800USD-10,235USD-720,150USD4,133USD
    Change In Working Capital126,809USD34,088USD223,219USD-219,316USD-541,377USD110,226USD712,961USD400,513USD
    Total Cash From Operating Activities-5,134,630USD-4,627,000USD-3,527,509USD-2,987,198USD-2,809,223USD-297,055USD-894,470USD-1,105,466USD
    Capital Expenditures-5,320USD-92,043USD-51,761USD-79,304USD-81,595USD-81,595USD-81,595USD-4,163USD
    Free Cash Flow-5,134,630USD-4,719,000USD-3,579,270USD-3,066,502USD-2,890,818USD-297,055USD-894,470USD-1,109,629USD
    Total Cashflows From Investing Activities-5,324USD-92,043USD-51,761USD-79,304USD-81,595USD66,994USD66,994USD-404,163USD
    Net Borrowings-21,617USD279,340USD2,086,772USD-17,795USD-1,627,040USD-194,890USD430,250USD-16,112USD
    Total Cash From Financing Activities5,403,092USD8,537,000USD2,086,771USD160,074USD7,630,693USD371,873USD430,250USD1,983,888USD
    Sale Purchase Of Stock0USD-149,000USD0USD-119,006USD-104,467USD575,108USD—0USD
    Issuance Of Capital Stock5,305,503USD8,406,591USD0USD0USD6,419,230USD515,108USD0USD1,500,000USD
    Change In Cash263,138USD3,819,000USD-1,492,498USD-2,906,428USD4,739,875USD141,812USD-464,472USD474,653USD
    Begin Period Cash Flow4,311,719USD492,942USD1,985,440USD4,891,868USD151,993USD10,181USD474,653USD92,886USD
    End Period Cash Flow4,574,857USD4,312,000USD492,942USD1,985,440USD4,891,868USD151,993USD10,181USD474,653USD
    Other Cashflows From Investing Activities-5,324USD-92,043USD—-79,304USD-81,595USD66,994USD—-404,163USD
    Other Cashflows From Financing Activities5,403,092USD-8,406,931USD-1USD296,875USD3,139,559USD18,306USD5,250USD461,470USD
    Investments—-92,043USD-51,761USD-79,304USD-81,595USD66,994USD0USD-404,163USD
    Unclassified Financing Cash Flow—16,813,591USD——6,419,230USD——1,538,530USD
    Change To Liabilities———-48,224USD-125,838USD205,097USD648,925USD351,427USD
    Dividends Paid———-296,875USD-196,589USD——0USD
    Cash And Cash Equivalents Changes—————141,812USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2026Yearly · 2026-01-31GeographyInternational7,630USD0001213900-26-049399
    FY 2026Yearly · 2026-01-31GeographyUnited States2,029,021USD0001213900-26-049399
    Q2 2026Quarterly · 2025-07-31GeographyForeign7,630USD0001213900-25-086270
    Q2 2026Quarterly · 2025-07-31GeographyUnited States614,822USD0001213900-25-086270
    FY 2024Yearly · 2024-01-31ProductSale Of Goods1,920,280USD0001213900-25-036201
    FY 2024Yearly · 2024-01-31ProductServices165,034USD0001213900-25-036201
    FY 2024Yearly · 2024-01-31SegmentFour PTherapeutics165,034USD0001213900-25-036201
    FY 2024Yearly · 2024-01-31SegmentPocono Pharmaceuticals1,920,280USD0001213900-25-036201
    Q2 2024Quarterly · 2023-07-31ProductSale Of Goods566,769USD0001213900-24-075159
    Q2 2024Quarterly · 2023-07-31ProductServices89,159USD0001213900-24-075159
    Q2 2024Quarterly · 2023-07-31SegmentFour PTherapeutics89,159USD0001213900-24-075159
    Q2 2024Quarterly · 2023-07-31SegmentPocono Pharmaceuticals566,769USD0001213900-24-075159
    Q1 2024Quarterly · 2023-04-30GeographyOutside The United States75,875USD0001213900-24-048363
    Q1 2024Quarterly · 2023-04-30GeographyUnited States401,057USD0001213900-24-048363
    Q1 2024Quarterly · 2023-04-30ProductSale Of Goods401,057USD0001213900-24-048363
    Q1 2024Quarterly · 2023-04-30ProductServices75,875USD0001213900-24-048363
    Q1 2024Quarterly · 2023-04-30SegmentFour PTherapeutics75,875USD0001213900-23-047881
    Q1 2024Quarterly · 2023-04-30SegmentPocono Pharmaceuticals401,057USD0001213900-23-047881
    Q2 2023Quarterly · 2022-07-31SegmentFour PTherapeutics61,245USD0001213900-23-075508
    Q2 2023Quarterly · 2022-07-31SegmentPocono Pharmaceuticals394,904USD0001213900-23-075508
    Q1 2023Quarterly · 2022-04-30SegmentFour PTherapeutics75,932USD0001213900-23-047881
    Q1 2023Quarterly · 2022-04-30SegmentPocono Pharmaceuticals401,990USD0001213900-23-047881
    Q1 2022Quarterly · 2021-04-30SegmentContract Services105,976USD0001213900-22-030469
    Q1 2022Quarterly · 2021-04-30SegmentTransdermal Patches327,512USD0001213900-22-030469
    FY 2021Yearly · 2021-01-31GeographyInternational86,600USD0001213900-21-032333
    FY 2021Yearly · 2021-01-31GeographyUS346,888USD0001213900-21-032333
    Q3 2021Quarterly · 2020-10-31GeographyInternational236,714USD0001213900-20-042751
    Q3 2021Quarterly · 2020-10-31GeographyUS155,083USD0001213900-20-042751
    Q2 2021Quarterly · 2020-07-31GeographyInternational59,450USD0001213900-21-046610
    Q2 2021Quarterly · 2020-07-31GeographyUnited States25,000USD0001213900-21-046610
    Q1 2021Quarterly · 2020-04-30GeographyInternational61,320USD0001213900-20-014088
    Q1 2021Quarterly · 2020-04-30GeographyUnited States58,044USD0001213900-20-014088
    FY 2020Yearly · 2020-01-31GeographyInternational61,320USD0001213900-21-032333
    FY 2020Yearly · 2020-01-31GeographyUS58,044USD0001213900-21-032333
    Q1 2020Quarterly · 2019-04-30GeographyInternational142,450USD0001213900-20-014088
    Q1 2020Quarterly · 2019-04-30GeographyUnited States51,140USD0001213900-20-014088
    FY 2019Yearly · 2019-01-31GeographyInternational49,000USD0001213900-20-009139
    FY 2019Yearly · 2019-01-31GeographyUnited States196,285USD0001213900-20-009139
    Q3 2019Quarterly · 2018-10-31GeographyInternational49,000USD0001213900-19-025956
    Q3 2019Quarterly · 2018-10-31GeographyUnited States113,815USD0001213900-19-025956

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.